Aspire Growth Partners’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$232K	Buy	102,254 +10,000	+11%	+$22.7K	0.19%	104
2025 Q1	$88.6K	Buy	92,254 +51,474	+126%	+$49.4K	0.08%	113
2024 Q4	$42K	Buy	+40,780	New	+$42K	0.04%	99